Evidence map›Paper›PMID 10958664›Full record

ArticleMolecular and cellular biology2000

Preferential accessibility of the yeast his3 promoter is determined by a general property of the DNA sequence, not by specific elements.

X Mai, S Chou, K Struhl

Open access · greenAbstract read
In one paragraph

Article in Molecular and cellular biology, 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 49 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

X MaiDepartment of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts 02115, USA.
S Chou
K Struhl
Harvard University · US

Funding

MOLECULAR MECHANISMS OF YEAST TRANSCRIPTIONAL INITIATIONR01GM030186 · NIGMS · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI STRUHL, KEVIN · 1985 to 2018
$13.6M
MECHANISMS OF YEAST TRANSCRIPTIONAL INITITATIONR37GM030186 · NIGMS · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI STRUHL, KEVIN · 1993 to 2002
$2.1M
NIGMS NIH HHS GM30186NIGMS NIH HHS R01 GM030186NIGMS NIH HHS R37 GM030186
6 · The paper itself

Abstract

Yeast promoter regions are often more accessible to nuclear proteins than are nonpromoter regions. As assayed by HinfI endonuclease cleavage in living yeast cells, HinfI sites located in the promoters of all seven genes tested were 5- to 20-fold more accessible than sites in adjacent nonpromoter regions. HinfI hypersensitivity within the his3 promoter region is locally determined, since it was observed when this region was translocated to the middle of the ade2 structural gene. Detailed analysis of the his3 promoter indicated that preferential accessibility is not determined by specific elements such as the Gcn4 binding site, poly(dA-dT) sequences, TATA elements, or initiator elements or by transcriptional activity. However, progressive deletion of the promoter region in either direction resulted in a progressive loss of HinfI accessibility. Preferential accessibility is independent of the Swi-Snf chromatin remodeling complex, Gcn5 histone acetylase complexes Ada and SAGA, and Rad6, which ubiquitinates histone H2B. These results suggest that preferential accessibility of the his3 (and presumably other) promoter regions is determined by a general property of the DNA sequence (e.g., base composition or a related feature) rather than by defined sequence elements. The organization of the compact yeast genome into inherently distinct promoter and nonpromoter regions may ensure that transcription factors bind preferentially to appropriate sites in promoters rather than to the excess of irrelevant but equally high-affinity sites in nonpromoter regions.

Indexed as

Nuclear ProteinsPromoter Regions, GeneticSaccharomyces cerevisiae ProteinsAdaptor Proteins, Signal TransducingAdenosine TriphosphatasesBinding SitesCarboxy-LyasesChromatinChromosomal Proteins, Non-HistoneDeoxyribonucleases, Type II Site-SpecificDNA-Binding ProteinsDNA, FungalFungal ProteinsGenes, FungalHistone AcetyltransferasesHydro-LyasesAdaptor Proteins, Signal TransducingAdenosine TriphosphatasesCarboxy-LyasesChromatinChromosomal Proteins, Non-HistoneDeoxyribonucleases, Type II Site-SpecificDNA-Binding ProteinsDNA, FungalFungal ProteinsGANTC-specific type II deoxyribonucleasesGCN5 protein, S cerevisiaeHFI1 protein, S cerevisiaeHistone AcetyltransferasesHydro-Lyasesimidazoleglycerolphosphate dehydrataseLigasesNuclear Proteinsp300-CBP-Associated Factorphosphoribosylaminoimidazole carboxylaseProtein KinasesRAD6 protein, S cerevisiaeSaccharomyces cerevisiae ProteinsSAGA protein, Emericella nidulansSNF2 protein, S cerevisiaeSWI1 protein, S cerevisiaeTrans-ActivatorsTranscription FactorsUbiquitin-Conjugating Enzymes

Identifiers

PMID10958664
PMCPMC86173
OpenAlexW2079524506

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.